Recovery of pDIKE2 plasmid for Hepatitis C Vaccine using CIMmultus C4 HLD Advanced Composite Column cGMP
4 September 2014

This application note demonstrates that in order to satisfy the high demanding plasmids consumption for clinical trials, a down-stream process was improved to reach the quantities need it for clinical trials.

Show    per page
1 of 2     Page  1 2 Next 
The Use of Radiolabelled Compounds in the Investigation of Metabolism and Drug-Drug Interactions In Vitro ADME, compound screening, Toxicology Screening22 Aug 2014Read
Overcoming Obstacles to Develop a Cancer Immunotherapeutic cancer cells, clinical study, gene therapy19 Aug 2014Read
7 Ways to Reduce Inflammation Study Challenges clinical study, inflammatory diseases5 Jun 2014Read
The Nut Thing - Oral Immunotherapy, a Personal Journey allergen2 Jun 2014Read
Bioenergetic Analysis of Suspension Cells: Hematopoietic Stem Cells and Lymphocytes immunoassay, assay development22 May 2014Read
Bioenergetic Analysis of Primary Neuronal Deficiencies cellular bioenergetics, synaptosomes, mitochondria21 May 2014Read
CAR mRNA Loaded Freshly Isolated Peripheral Blood Lymphocytes as Rapid, Targeted Tumor Immunotherapy cancer, transfection, lymphocytes19 May 2014Read
MALDI Imaging Success Stories in Clinical Research clinical study, pharmaceuticals8 May 2014Read
Identifying Products for Drug Development Programs pharmaceuticals15 Mar 2014Read
CMC for 505(b)(2) Applications pharmaceuticals10 Mar 2014Read

Popular tags in SelectScience

Buying guides